The 'Pfizer machine'

CEO Albert Bourla is optimistic about the company that 'saved the world,' despite its 'spiral of losing credibility'

January 14, 2025 Check out STAT+

Sponsored By

STAT STAT+ | Defiant, Pfizer CEO talks about Trump, obesity drugs, and the 'Pfizer machine' At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's obesity and oncology drugs By Matthew Herper STAT+ | Eli Lilly scientific chief Skovronsky says Scorpion deal 'checked all the boxes' In JPM news, the drugmaker will buy the startup and then spin it back out, but keep one of its cancer therapies, STX-478. By Matthew Herper STAT+ | GSK to buy cancer-focused IDRx in $1 billion deal GSK, which has been building up its cancer business, will get an experimental drug for a rare cancer known as GIST. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser